Sais e Derivados de API
Os sais dos Ingredientes Farmacêuticos Ativos (API) são compostos formados pela reação de um ácido com uma base, resultando em um equilíbrio iônico. Esses sais frequentemente melhoram a solubilidade e a estabilidade dos APIs, facilitando sua absorção no organismo. Os derivados de API são variantes químicas de um princípio ativo que podem apresentar propriedades aprimoradas ou modificadas para otimizar a eficácia terapêutica. Os sais de APIs são utilizados na formulação de medicamentos orais, injetáveis e tópicos. Além disso, os derivados de API podem melhorar a farmacocinética dos fármacos, permitindo, por exemplo, a liberação controlada de substâncias ativas.
Na CymitQuimica, oferecemos sais e derivados de APIs com a pureza e qualidade necessárias para pesquisa e desenvolvimento de formulações farmacêuticas.
Foram encontrados 79382 produtos de "Sais e Derivados de API"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Nebivolol Related Compound E (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride)
Aromatic pesticides with oxygen heteroFórmula:C22H26FNO4·HClCor e Forma:PowderPeso molecular:423.16126Amitraz Related Compound A (N-(2,4-Dimethylphenyl)formamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H11NOCor e Forma:PowderPeso molecular:149.08406Atenolol Related Compound E (2,2'-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C19H22N2O5Cor e Forma:White SolidPeso molecular:358.15287Fludeoxyglucose Related Compound A (4,7,13,16,21,24-hexaoxa-1,10-diazabicyclo[8.8.8]hexacosane)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H36N2O6Cor e Forma:Colorless Light Yellow Crystalline SolidPeso molecular:376.25734Acetaminophen Related Compound A (4-(acetylamino)phenyl acetate)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C10H11NO3Cor e Forma:White PowderPeso molecular:193.07389Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)
CAS:Other quinonesFórmula:C12H16O2Cor e Forma:Yellow LiquidPeso molecular:192.11503Adapalene Related Compound C (2-(adamant-1-yl)methoxybenzene)
CAS:Aromatic ethers and their halogenated, sulfonated, nitrated or nitrosated derivativesFórmula:C17H22OCor e Forma:PowderPeso molecular:242.16707Ticagrelor R,S-Cyclopropyl Isomer
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H28F2N6O4SCor e Forma:White Off-White SolidPeso molecular:522.18608Pancuronium Bromide Related Compound A (1,1'-(3α,17β-dihydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C31H56N2O2·2BrCor e Forma:White Off-White Crystalline PowderPeso molecular:488.43418Diazepam Related Compound E (6-Chloro-1-methyl-4-phenylquinazolin-2(1H)-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C15H11ClN2OCor e Forma:Off-White PowderPeso molecular:270.05599Methyldopa Related Compound B ((S)-2-Amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C11H15NO3·HClCor e Forma:Grey PowderPeso molecular:245.08187Decitabine Related Compound A (1-O-Acetyl-3,5-di-O-(4-chlorobenzoyl)-2-deoxy-D-ribofuranose)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFórmula:C21H18Cl2O7Cor e Forma:Off-White White PowderPeso molecular:452.04296Dopamine Related Compound C (2-(3,4-Dimethoxyphenyl)ethan-1-amine)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFórmula:C10H15NO2Cor e Forma:Yellow Brown LiquidPeso molecular:181.11028Dimethyl Sulfoxide
CAS:Organo-sulfur compounds, nesoiFórmula:C2H6OSCor e Forma:Clear LiquidPeso molecular:78.01394Bisoprolol Related Compound E (3,3'-(Isopropylazanediyl)bis(1-(4-((2-isopropoxyethoxy)methyl)phenoxy)propan-2-ol))
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C33H53NO8Cor e Forma:Colorless Gummy LiquidPeso molecular:591.37712Iohexol Related Compound B (5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H18I3N3O6Cor e Forma:Off-White SolidPeso molecular:704.83298Valsartan Related Compound B (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C23H27N5O3Cor e Forma:White PowderPeso molecular:421.21139o-Iodohippuric Acid
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C9H8INO3Cor e Forma:PowderPeso molecular:304.95489D-Valganciclovir (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-methoxy]-3-hydroxypropyl D-valine ester monohydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O5·HCICor e Forma:Off-White PowderPeso molecular:494.07746Salicylic Acid Related Compound A (4-hydroxybenzoic acid)
CAS:Carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides etc nesoiFórmula:C7H6O3Cor e Forma:White PowderPeso molecular:138.03169Voriconazole Related Compound C (1-(2,4-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone)
Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C10H7F2N3OCor e Forma:Pale Yellow SolidPeso molecular:223.05572Doxazosin Related Compound D (1,4-benzodioxane-2-carboxylic acid)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C9H8O4Cor e Forma:Off-White Crystalline PowderPeso molecular:180.04226Fosinopril Related Compound E ((4S)-4-Phenyl-1-[(R)-[(S)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]acetyl-L-proline propionate (ester), sodium salt)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H39NNaO7PCor e Forma:White PowderPeso molecular:579.23618Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C11H15NO4Cor e Forma:White PowderPeso molecular:225.10011Probucol Related Compound A (2,2',6,6'-tetra-tert-butyldiphenoquinone)
CAS:Other quinonesFórmula:C28H40O2Cor e Forma:Purple CrystalsPeso molecular:408.30283Aripiprazole Related Compound H (7-(4-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}butoxy)-3,4-dihydroquinolin-2(1H)-one)
Lactams, nesoiFórmula:C27H35Cl2N3O3Cor e Forma:White Pale Yellow Crystalline PowderPeso molecular:519.20555Tropicamide Related Compound A (N-(pyridin-4-ylmethyl)ethanamine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C8H12N2Cor e Forma:LiquidPeso molecular:136.10005Amitriptyline Related Compound A (dibenzosuberone)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C15H12OCor e Forma:Pale Yellow PowderPeso molecular:208.08882Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H10ClNOCor e Forma:Light Yellow PowderPeso molecular:243.04509Losartan Related Compound E (4'-[({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-2H-tetrazol-2-yl)methyl]-4-chloro-1H-imidazol-1- yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C44H43Cl2KN12OCor e Forma:PowderPeso molecular:864.26969Dabigatran Etexilate Mesylate
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C34H41N7O5·CH4O3SCor e Forma:White Off-White Yellow PowderPeso molecular:723.30503Memantine Related Compound C (1-Chloro-3,5-dimethyladamantane)
CAS:<p>Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexane</p>Fórmula:C12H19ClCor e Forma:Light Yellow LiquidPeso molecular:198.11753Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H18Cl2N4O6andC22H18Cl2N4O6Cor e Forma:White PowderPeso molecular:504.06034Methoxsalen Related Compound B (4,9-Dimethoxy-7H-furo[3,2-g]chromen-7-one)
CAS:Aromatic lactones used as drugsFórmula:C13H10O5Cor e Forma:PowderPeso molecular:246.05282Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C22H32N2O4Cor e Forma:White SolidPeso molecular:388.23621Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C20H24N2Cor e Forma:Pale Yellow SolidPeso molecular:292.19395Urea
CAS:Urea, whether or not in aqueous solutionFórmula:CH4N2OCor e Forma:White Powder CrystalsPeso molecular:60.03236Trazodone Related Compound F (1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine hydrochloride)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C13H18Cl2N2·ClHCor e Forma:White PowderPeso molecular:308.06138Aminophenylmorpholinone (4-(4-aminophenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C10H12N2O2Cor e Forma:White Off-White SolidPeso molecular:192.08988Phenyltoloxamine Related Compound A (2-(2-Benzylphenoxy)ethylmethylamine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFórmula:C16H19NO·HClCor e Forma:White Light Yellow PowderPeso molecular:241.14666Triethylamine
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C6H15NCor e Forma:Clear Colorless LiquidPeso molecular:101.12045Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H18N2O3SCor e Forma:PowderPeso molecular:270.10381Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoic acid 1,1, dimethylethyl ester)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C28H34FNO4Cor e Forma:PowderPeso molecular:467.24719Hyoscyamine Related Compound A (Norhyoscyamine Sulfate)
Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:(C16H21NO3)2H2SO4Cor e Forma:White PowderPeso molecular:648.77Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H11NO6P2Cor e Forma:White Crystalline PowderPeso molecular:267.00616Lorazepam Related Compound B (2-Amino-2',5-dichlorobenzophenone)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H9Cl2NOCor e Forma:Yellow Crystalline PowderPeso molecular:265.00612Valacyclovir Related Compound F (2-hydroxyethyl valinate para-toluenesulfonate salt)
CAS:Non-aromatic amino-compounds with oxygen functionFórmula:C7H15NO3·C7H8O3SCor e Forma:White Off-White PowderPeso molecular:161.10519Chloropropiophenone (1-(3-Chlorophenyl)propan-1-one)
CAS:Aromatic ketones without other oxygen function, nesoiFórmula:C9H9ClOCor e Forma:White Yellow SolidPeso molecular:168.03419Dermatan Sulfate
CAS:Natural polymers & modified natural polymers, in primary forms, nesoiCor e Forma:White PowderPeso molecular:Average 46275Atomoxetine Related Compound B ((R)-N-Methyl-3-phenyl-3-(3-tolyloxy)propan-1-amine hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C17H21NO·HClCor e Forma:Off-White Crystalline SolidPeso molecular:255.16231Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C11H9NO3Cor e Forma:Off-White PowderPeso molecular:203.05824Famciclovir Related Compound E (2-aminopurine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C5H5N5Cor e Forma:PowderPeso molecular:135.0545Prednicarbate Related Compound A (1,2-Dihydroprednicarbate)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C27H38O8Cor e Forma:White PowderPeso molecular:490.25667Pramipexole Related Compound A ((S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C7H11N3SCor e Forma:Off-White Light Brown Grey PowderPeso molecular:169.067371,2-Dinitroglycerin
CAS:Esters of other inorganic acids of nonmetals & their salts, their halogenated/sulfonated/nitrated/nitrosated derivs, except of hydrogen halides, nesoiFórmula:C3H6N2O7Cor e Forma:Clear Colorless LiquidPeso molecular:182.0175Brimonidine Related Compound E (2-(5-Bromoquinoxalin-6-yl)guanidine dihydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C9H8BrN5Cor e Forma:Brown PowderPeso molecular:264.99631Verapamil Related Compound F ((3,4-Dimethoxyphenyl)methanol)
CAS:Ether-alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C9H12O3Cor e Forma:Colorless Light Yellow Clear Liquid ViscousPeso molecular:168.07864Orlistat Related Compound C (Triphenylphosphine Oxide)
CAS:Non-halogenated organo-phosphorous derivatives, nesoiFórmula:C18H15OPCor e Forma:White Beige PowderPeso molecular:278.08605Sevoflurane Related Compound C (1,1,1,3,3,3-hexafluoro-2-propanol)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of acyclic alcohols, nesoi (excluding ethchlorovynol [inn])Fórmula:C3H2F6OCor e Forma:Clear Colorless LiquidPeso molecular:168.00098Chloroquine Related Compound E (N4-(5-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine oxalate)
Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFórmula:C20H28ClN3O4Cor e Forma:White SolidPeso molecular:409.17683Irbesartan Related Compound A (1-pentanoylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C25H30N6O2Cor e Forma:White PowderPeso molecular:446.24302Quinapril Related Compound B (3-Isoquinolinecarboxylic acid, 2-[2-[(1-carboxy-3-phenylpropyl)amino]-1-oxopropyl]-1,2,3,4-tetrahydro-,[3S-[2[R*(R*)],3R*]])
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFórmula:C23H26N2O5Cor e Forma:White PowderPeso molecular:410.18417Amoxicillin Related Compound J (Mixture of amoxicillin and amoxicillin related compound J (amoxicillin open ring dimer))
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White Yellow PowderFamciclovir Related Compound B (4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C12H17N5O3Cor e Forma:Off-White PowderPeso molecular:279.13314Bisacodyl Related Compound E (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C22H19NO4Cor e Forma:White Off-White PowderPeso molecular:361.13141Gadoteridol Related Compound C (1,4,7,10-Tetraaza-11-oxo-bicyclo[8.2.2]tetradecane-4,7-diacetic acid)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFórmula:C14H24N4O5Cor e Forma:White Light Yellow PowderPeso molecular:328.17467Celecoxib Related Compound C (4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C18H16F3N3O2SCor e Forma:SolidPeso molecular:395.09153Pramipexole Related Compound G ((6S,7S)-2-Amino-6-(propylamino)-4,5,6,7-tetrahydrobenzothiazol-7-ol)
CAS:Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFórmula:C10H17N3OSCor e Forma:Off-White SolidPeso molecular:227.10923Metformin Related Compound C (N,N-Dimethyl-[1,3,5]triazine-2,4,6-triamine)
CAS:Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFórmula:C5H10N6Cor e Forma:White Off-White PowderPeso molecular:154.09669N-Demethylazithromycin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C37H70N2O12Cor e Forma:White PowderPeso molecular:734.49288Benazepril Related Compound D (3-(1-Ethoxycarbonyl-3-cyclohexyl-(1S)-propyl)amino-2,3,4,5-tetrahydro-2-oxo-1H-1-(3S)-benzazepine-1-acetic acid monohydrochloride)
CAS:Lactams, nesoiFórmula:C24H34N2O5·HClCor e Forma:White Fine PowderPeso molecular:430.24677Buspirone Related Compound A (2-(Piperazin-1-yl)pyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C8H12N4Cor e Forma:Clear Light Yellow LiquidPeso molecular:164.1062Promethazine Related Compound B (N,N-Dimethyl-2-(10H-phenothiazin-10-yl)propan-1-amine hydrochloride)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C17H20N2S·HClCor e Forma:White PowderPeso molecular:320.1114Ketorolac Related Compound C (5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-one)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C14H11NO2Cor e Forma:Yellow SolidPeso molecular:225.07898Norgestrel Related Compound L (13-Ethylgon-4-ene-3,17-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C19H26O2Cor e Forma:White SolidPeso molecular:286.19328Memantine Related Compound A (1,3-Dimethyladamantane)
CAS:Cyclanes, cyclenes and cycloterpenes, excluding cyclohexaneFórmula:C12H20Cor e Forma:Clear Colorless LiquidPeso molecular:164.1565Ranolazine Related Compound B (N-(2,6-Dimethylphenyl)-2-[4-(2-hydroxy-3-phenoxypropyl)piperazin-1-yl]acetamide dihydrochloride monohydrate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H31N3O3Cor e Forma:White PowderPeso molecular:397.23654Spironolactone Related Compound A ((2'R)-3',4'-Dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C22H28O3Cor e Forma:Light Yellow Crystalline PowderPeso molecular:340.20384m-Aminophenol
CAS:Amino-naphthols and other amino-phenols, their ethers aFórmula:C6H7NOCor e Forma:White Pale Yellow PowderPeso molecular:109.12 g/molClomipramine Related Compound F (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)
CAS:Aromatic or modified aromatic drugs with nitrogen heteroFórmula:C14H12ClNCor e Forma:Off-White SolidPeso molecular:229.06583Atenolol Related Compound A (2-(4-Hydroxyphenyl)acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C8H9NO2Cor e Forma:Light Cream PowderPeso molecular:151.06333Bendamustine Related Compound G (4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H20ClN3O2S·HClCor e Forma:Off-White Light Brown SolidPeso molecular:389.07315Glycopyrrolate Related Compound I ((RS)-3-[(SR)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)
Aromatic or modified aromatic heterocyclic compounds wiFórmula:C19H27BrClNO3Cor e Forma:White SolidPeso molecular:431.08628Carbinoxamine Related Compound C (N,N-Dimethyl-2-[phenyl(pyridin-2-yl)methoxy]ethan-1-amine oxalate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C16H20N2O·C2H2O4Cor e Forma:White PowderPeso molecular:346.15287Bumetanide Related Compound B (3-Nitro-4-phenoxy-5-sulfamoylbenzoic Acid)
CAS:Sulfonamides, nesoiFórmula:C13H10N2O7SCor e Forma:Light Yellow PowderPeso molecular:338.02087Memantine Related Compound F (3-Amino-5,7-dimethyladamantan-1-ol hydrochloride)
CAS:Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFórmula:C12H21NO·HClCor e Forma:White PowderPeso molecular:231.13899Mefloquine Related Compound A (threo-mefloquine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H16F6N2O·HClCor e Forma:White PowderPeso molecular:378.11668Rivaroxaban Related Compound D (1,3-Bis({(S)-2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)urea)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C29H32N6O9Cor e Forma:Off-White White SolidPeso molecular:608.22308Dopamine Related Compound B (4-(2-Aminoethyl)-2-methoxyphenol hydrochloride)
CAS:Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof nesoiFórmula:C9H13NO2·HClCor e Forma:Off-White SolidPeso molecular:203.07131Linezolid Related Compound A ((R)-5-(azidomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H16FN5O3Cor e Forma:White PowderPeso molecular:321.12372Potassium Trichloroammineplatinate
CAS:Inorganic or organic compounds of precious metals, whether or not chemically defined; amalgrams of precious metals, nesoiFórmula:Cl3H3KNPtCor e Forma:Orange Yellow CrystalsPeso molecular:355.86161Tenofovir Disoproxil Related Compound G (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-{(R)-[1-(6-amino-9H-purin-9-yl)propan-2-yloxy]}methylphosphonate) fumarate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C17H28N5O7P·C4H4O4Cor e Forma:PowderPeso molecular:445.17264Tiamulin Related Compound A (Tosyl pleuromutilin)
CAS:Antibiotics nesoiFórmula:C29H40O7SCor e Forma:PowderPeso molecular:532.69Thimerosal Related Compound A (2,2'-Disulfanediyldibenzoic acid)
CAS:Other aromatic organoFórmula:C14H10O4S2Cor e Forma:PowderPeso molecular:306.00205Ecamsule Triethanolamine
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives: chlordecone (iso)Fórmula:C28H34O8S2·(C6H15NO3)2Cor e Forma:White Cream PowderPeso molecular:562.16951Ecamsule Related Compound A (1,4-Phenylenedimethanol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C8H10O2Cor e Forma:White Crystalline PowderPeso molecular:138.06808Dichlorothienoic Acid (4,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H2Cl2O2SCor e Forma:Off-White SolidPeso molecular:195.91526Bosentan Related Compound B (4-(tert-butyl)-N-[6-hydroxy-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C25H25N5O5SCor e Forma:White PowderPeso molecular:507.15764Ciclopirox Related Compound C (6-Cyclohexyl-4-methylpyridin-2(1H)-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C12H17NOCor e Forma:White Yellow PowderPeso molecular:191.13101Acetylcysteine Related Compound D (N,S-Diacetyl-L-Cysteine)
CAS:Other organo-sulfur acid compoundsFórmula:C7H11NO4SCor e Forma:White SolidPeso molecular:205.04088Nicotine Related Compound E ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H14N2OCor e Forma:White Off-White PowderPeso molecular:178.11061Loxapine N-Oxide (4-(2-Chlorodibenzo[b,f][1,4]oxazepin-11-yl)-1-methylpiperazine 1-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H18ClN3O2Cor e Forma:White Off-White Pale Yellow SolidPeso molecular:343.10875[D-His1]-Exenatide
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C184H282N50O60SCor e Forma:White CrystalsPeso molecular:4184.02731Argatroban Related Compound C ((2R,4R)-1-[N^8-amino- N^2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonyl)-L-arginyl]-4-methylpiperidine-2-carboxylic acid)
Sulfonamides, excluding drugsFórmula:C23H37N7O5SCor e Forma:Off-White PowderPeso molecular:523.25769Flutamide Related Compound B (N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C9H7F3N2O3Cor e Forma:PowderPeso molecular:248.04088Bosentan Related Compound D (4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C15H10Cl2N4O2Cor e Forma:Yellow PowderPeso molecular:348.01808Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H19N3O6Cor e Forma:White Off-White SolidPeso molecular:421.12739Famotidine Related Compound E (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C10H14N8S4Cor e Forma:White Beige PowderPeso molecular:374.02243Cidofovir Enantiomer (1-[(R)-3-Hydroxy-2-(phosphonomethoxy)propyl]cytosine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C8H14N3O6PCor e Forma:White Off-White PowderPeso molecular:279.06202Methoxymethylguanine
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C7H9N5O2Cor e Forma:Light Yellow PowderPeso molecular:195.07562Paclitaxel Related Compound A (Cephalomannine)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C45H53NO14Cor e Forma:White Off-White PowderPeso molecular:831.34661Pyridostigmine Related Compound B (3-Hydroxy-1-methylpyridin-1-ium bromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C6H8BrNOCor e Forma:White Off-White SolidPeso molecular:188.97893Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C17H19N3O·H2OCor e Forma:Off-White White PowderPeso molecular:281.15281Phenylephrine Related Compound E (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFórmula:C16H17NO2·HClCor e Forma:Grey To White PowderPeso molecular:291.10261Benzalkonium Chloride (5 mL of approx. 4% aqueous solution)
CAS:<p>Cationic organic surface-active agents,other than aromatic or modified aromatic, whether or not for retail sale</p>Cor e Forma:Clear Colorless LiquidTriclocarban Related Compound D Mixture (Mixture of 3,5-Bis(4-chlorophenyl)-1-(3,4-dichlorophenyl)biuret and 1,5-Bis(4-chlorophenyl)-3-(3,4-dichlorophenyl)biuret)
Ureines and their derivatives; salts thereofFórmula:C20H13Cl4N3O2Cor e Forma:PowderPeso molecular:466.97619Lomustine Related Compound C (1,3-Dicyclohexylurea)
CAS:Ureines and their derivatives; salts thereofFórmula:C13H24N2OCor e Forma:White PowderPeso molecular:224.18886Quazepam Related Compound A (7-Chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H11ClF4N2OCor e Forma:Off-White Cream PowderPeso molecular:370.0496Acetaminophen Related Compound F (p-nitrophenol)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatives of phenols or phenol-alcohols, nesoiFórmula:C6H5NO3Cor e Forma:PowderPeso molecular:139.02694Sodium Sulfate Anhydrous
CAS:Disodium sulfate, except salt cake, nesoiFórmula:Na2SO4Cor e Forma:White Crystalline Powder Crystalline GranulesPeso molecular:141.93127Flumazenil Related Compound A (8-Fluoro-5-methyl-6-oxo-5,6-dihydro-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylic acid)
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C13H10FN3O3Cor e Forma:White PowderPeso molecular:275.24Nicotine Related Compound A (1,2,3,6-tetrahydro-2,3'-bipyridine)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C10H12N2Cor e Forma:Pale Yellow Light Brown LiquidPeso molecular:160.10005Fluoroquinolonic Acid
CAS:Compounds (excluding drugs and pesticides) containing aFórmula:C13H9ClFNO3Cor e Forma:Beige PowderPeso molecular:281.0255Nevirapine Related Compound B (5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C12H10N4OCor e Forma:Yellow Green PowderPeso molecular:226.08546Cefadroxil Related Compound I ((6R,7R)-7-[(R)-2-amino-2-(4-hydroxyphenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS:Aminoglycoside antibioticsFórmula:C16H17N3O5SCor e Forma:Off-White PowderPeso molecular:363.08889Tiagabine Isomer (1-(4,4-Bis(4-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H25NO2S2Cor e Forma:Brown SolidPeso molecular:375.13267Abacavir Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:PowderIopromide Related Compound A (5-Amino-N1,N3-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-N1-methylisophthalamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C15H20I3N3O6Cor e Forma:White Crystalline PowderPeso molecular:718.84863Rabeprazole Related Compound A (Sodium 1-(1H-benzimidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate)
Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C14H9N3NaxO3Cor e Forma:Off-White Yellow PowderPeso molecular:313.04393Citalopram Related Compound H (3-[5-Bromo-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-1-yl]-N,N-dimethylpropan-1-amine hydrobromide)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C19H21BrFNO·HBrCor e Forma:White Off-White Crystalline PowderPeso molecular:377.07906Sibutramine Related Compound A (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or includedFórmula:C17H26ClN·HCl·H2OCor e Forma:White Crystalline PowderPeso molecular:334.3Tioconazole Related Compound A (1-[2,4-Dichloro-β-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C16H14Cl2N2OS·HClCor e Forma:White Off-White PowderPeso molecular:352.02039Rufinamide Related Compound A (1-(2-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C10H9FN4OCor e Forma:White PowderPeso molecular:220.07604Amiloride Related Compound A (Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C6H7ClN4O2Cor e Forma:PowderPeso molecular:202.02575Bimatoprost Related Compound A ((E)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl]-N-ethylhept-5-enamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C25H37NO4Cor e Forma:LiquidPeso molecular:415.27226Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H25N3O3SCor e Forma:PowderPeso molecular:399.16166Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS:Sulfonamides, nesoiFórmula:C12H21N3O5S3Cor e Forma:White Off-White PowderPeso molecular:383.06433Dichlorothiophene Carboxylic Acid (3,5-dichlorothiophene-2-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C5H2Cl2O2SCor e Forma:White Off-White SolidPeso molecular:195.91526Gatifloxacin Related Compound D (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Products described in u.s. note 3 to section 6 containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C18H20FN3O4Cor e Forma:SolidPeso molecular:361.14378Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H13N5O4Cor e Forma:White Yellow Crystalline PowderPeso molecular:267.09675Iohexol Related Compound C (N,N'-Bis(2,3-dihydroxypropyl)-5-nitro-1,3- benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C14H19N3O8Cor e Forma:White PowderPeso molecular:357.11721Cefotaxime Related Compound E ((Z)-2-(2-aminothiazol-4-yl)-N-{(5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl}-2-(methoxyimino)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H13N5O5S2Cor e Forma:Off-White Light Yellow PowderPeso molecular:395.03581Phenylephrine Related Compound C (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride)
CAS:Aromatic amino-alcohol-phenols, aromatic amino-acid-pheFórmula:C9H11NO2·HClCor e Forma:Yellow Yellow Green PowderPeso molecular:201.05566Benztropine Related Compound A ((1R,3r,5S)-3-(Benzhydryloxy)-8-azabicyclo[3.2.1]octane hydrochloride)
CAS:Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFórmula:C20H23NO·HClCor e Forma:White Off-White SolidPeso molecular:293.17796Chlorobenzhydryl Piperazine
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C17H19ClN2Cor e Forma:White Off-White PowderPeso molecular:286.12368Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C44H43Cl2KN12OCor e Forma:PowderPeso molecular:864.26969Fluphenazine Related Compound A (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5-oxide)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C22H26F3N3O2SCor e Forma:Off-White Light Orange SolidPeso molecular:453.16978Valacyclovir Related Compound C (2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C14H22N6O4·HClCor e Forma:White PowderPeso molecular:338.17025Zolmitriptan Related Compound F (2,2'-[4-(Dimethylamino)butane-1,1-diyl]bis{5-[(S)-(2-oxooxazolidin-4-yl)methyl]-3-(2-dimethylaminoethyl)indole})
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H53N7O4Cor e Forma:Orange PowderPeso molecular:671.4159Citalopram Related Compound A (1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide)
CAS:Aromatic pesticides with oxygen hetero-atom(s) only neFórmula:C20H23FN2O2Cor e Forma:Cream PowderPeso molecular:342.17436Alcohol
CAS:Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFórmula:C2H6OCor e Forma:Clear Colorless LiquidPeso molecular:46.07Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C15H20N2Cor e Forma:White SolidPeso molecular:228.16265Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS:Aromatic or modified aromatic drugs with nitrogen heterFórmula:C12H10N6OCor e Forma:Light Yellow Crystalline PowderPeso molecular:254.09161Desbenzyl Donepezil Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H23NO3·HClCor e Forma:Yellow Off-White PowderPeso molecular:325.14447Famciclovir Related Compound F (2-Amino-6-chloropurine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H4ClN5Cor e Forma:Light Yellow Off-White PowderPeso molecular:169.01552Ziprasidone Related Compound F (Sodium 2-(2-amino-5-{2-[4-(benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-4-chlorophenyl)acetate monohydrate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C21H22ClN4NaO2S·H2OCor e Forma:White Off-White SolidPeso molecular:470.11553Pancuronium Bromide Related Compound C (1,1'-(3α-acetoxy-17β-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C33H58N2O3·2BrCor e Forma:White Crystalline PowderPeso molecular:530.44474Ramipril Related Compound D (Ethyl (S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoate)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C23H30N2O4Cor e Forma:White PowderPeso molecular:398.22056Beclomethasone Dipropionate Related Compound A (9-Chloro-11β,17-dihydroxy-16β-methyl-3,20-dioxopregna-1,4-diene-21-yl propionate)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc, nesoiFórmula:C25H33ClO6Cor e Forma:White Off-White PowderPeso molecular:464.19657Azithromycin N-Oxide
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C38H72N2O13Cor e Forma:White Crystalline PowderPeso molecular:764.50344Modafinil Sulfone
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C15H15NO3SCor e Forma:White Off-White PowderPeso molecular:289.07726Dimenhydrinate Related Compound E (8-chloro-3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione)
CAS:Vegetable alkaloids, natural or reproduced by synthesis, their salts and other derivatives, nesoiFórmula:C8H9ClN4O2Cor e Forma:White Off-White PowderPeso molecular:228.0414Ecamsule Related Compound G (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
CAS:Halogenated, sulfonated, nitrated or nitrosated derivatFórmula:C18H19NaO5SCor e Forma:White PowderPeso molecular:370.4Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS:Cyclanic, cyclenic or cycloterpenic ketones without othFórmula:C20H26O2Cor e Forma:PowderPeso molecular:240.0Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS:Compounds containing an unfused imidazole ring (whetherFórmula:C20H20Cl4N6Cor e Forma:White Off-White PowderPeso molecular:486.23Meclizine Related Compound A (4-Chlorobenzhydrol)
CAS:Compounds containing a pyrimidine ring (whether or notFórmula:C13H11ClOCor e Forma:White PowderPeso molecular:218.04984Imiquimod Related Compound D (1-Propyl-1H-imidazo[4,5-c]quinolin-4-amine)
CAS:<p>Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoi</p>Fórmula:C13H14N4Cor e Forma:Off-White PowderPeso molecular:226.12185Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS:Acyclic monoamines and their derivatives, nesoiFórmula:C3H9NO3SCor e Forma:PowderPeso molecular:139.03031Apixaban Related Compound G (Ethyl 6-[4-(5-bromopentanamido)phenyl]-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFórmula:C27H29BrN4O5Cor e Forma:Cream PowderPeso molecular:568.13213Bosentan Related Compound E (4-(tert-butyl)benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C10H15NO2SCor e Forma:PowderPeso molecular:213.08235Iopromide Related Compound B (5-(Acetylamino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C17H22I3N3O7Cor e Forma:White Off-White PowderPeso molecular:760.85919Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS:Lactams not elsewhere specified or includedFórmula:C15H10ClN3O3Cor e Forma:Yellow-Orange PowderPeso molecular:315.04107N-Ethylpiperazine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C6H14N2Cor e Forma:Colorless LiquidPeso molecular:114.1157Norfloxacin Related Compound A (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C12H9ClFNO3Cor e Forma:White PowderPeso molecular:269.0255Benzhydrol
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFórmula:C13H12OCor e Forma:White Off-White PowderPeso molecular:184.08882Dantrolene Related Compound B (5-(4-nitrophenyl)-2-furaldehyde-(2-carboxymethyl) semicarbazone)
CAS:Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFórmula:C14H12N4O6Cor e Forma:Yellow PowderPeso molecular:332.07568Cyclizine Related Compound A (1-Methylpiperazine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C5H12N2Cor e Forma:Colorless Clear Pale Yellow LiquidPeso molecular:100.10005Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS:Lactones, nesoiFórmula:C27H40O6Cor e Forma:PowderPeso molecular:460.28249Budesonide Related Compound G (16α,17-[butylidenebis(oxy)]-11β, 21-dihydroxypregna-4-ene-3,20-dione)
CAS:Adrenal cortical hormones and their derivatives nesoiFórmula:C25H36O6Cor e Forma:Off-White PowderPeso molecular:432.25119Progesterone Related Compound H (Pregna-4,6-diene-3,20-dione)
CAS:Estrogens and progestinsFórmula:C21H30O2Cor e Forma:Pale Yellow Off-White PowderPeso molecular:314.22458Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H6N6OCor e Forma:White Off-White Crystalline PowderPeso molecular:178.06031Tacrolimus Related Compound A (See USP Certificate for full Chemical Name)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C43H69NO12Cor e Forma:White Light Yellow PowderPeso molecular:791.48198Pravastatin Related Compound A (Sodium (3R,5R)-3,5-dihydroxy-7-[(1S,2R,3S,8S,8aR)-3-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] heptanoate)
CAS:Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFórmula:C23H35NaO7Cor e Forma:White Off-White PowderPeso molecular:446.22805Haloperidol Related Compound A (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]butyrophenone)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C32H36Cl2N2O3Cor e Forma:White PowderPeso molecular:566.2103R-Omeprazole (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H19N3O3SCor e Forma:White PowderPeso molecular:345.11471Oxymetholone Related Compound B (17β-Hydroxy-1-hydroxymethylene-17α-methyl-5α-androstan-3-one)
CAS:Ketone-alcohols and ketone-aldehydes, nesoiFórmula:C21H32O3Cor e Forma:Off-White Light Yellow SolidPeso molecular:332.23514Prochlorperazine Related Compound A (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride)
CAS:Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFórmula:C20H24ClN3S·2HClCor e Forma:Light Grey PowderPeso molecular:373.13795Indomethacin Related Compound B (4-Chlorobenzoic acid)
CAS:Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoiFórmula:C7H5ClO2Cor e Forma:White Off-White PowderPeso molecular:155.99781Abacavir Related Compound B ([4-(2,5-diamino-6-chloropyrimidin-4-ylamino)cyclopent-2-enyl]methanol)
Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C10H14ON4ClCor e Forma:Cream PowderPeso molecular:241.08561Terbinafine Related Compound D ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride)
CAS:Aromatic monoamines and their derivatives, salts thereof, nesoiFórmula:C22H27N·HClCor e Forma:White PowderPeso molecular:305.21435Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS:Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFórmula:C32H43NO6Cor e Forma:Light Grey Blue PowderPeso molecular:537.30904Glyburide Related Compound A (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide)
CAS:Sulfonamides, nesoiFórmula:C16H17ClN2O4SCor e Forma:White Crystalline PowderPeso molecular:368.05976(Z)-N'-Methylmeloxicam ((Z)-N-(3,5-dimethylthiazol-2(3H)-ylidene)-4-hydroxy-2-methyl-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C15H15N3O4S2Cor e Forma:PowderPeso molecular:365.0504Acetaminophen Related Compound C (N-(2-hydroxyphenyl)acetamide)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C8H9NO2Cor e Forma:Tan PowderPeso molecular:151.06333Azelastine Related Compound B (N'-(1-methylazepan-4-yl)benzohydrazide hydrochloride)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C14H21N3O·HClCor e Forma:White PowderPeso molecular:283.14514Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)
CAS:Aromatic cyclic amides (including cyclic carbamates) anFórmula:C13H20N2O2Cor e Forma:Yellow LiquidPeso molecular:236.15248Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFórmula:C7H6F3NCor e Forma:White Light Yellow LiquidPeso molecular:161.04523Rabeprazole Related Compound D (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C18H21N3O4SCor e Forma:White Light Yellow PowderPeso molecular:375.12528
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078835.webp&w=3840&q=75)
![Trimipramine Related Compound A (3-(5H-Dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1692710.webp&w=3840&q=75)
![Fluvastatin Related Compound B ([R*,S*-E]-(+/-)-7-[3-(4-fluorophenyl)-1-methylethyl-1H-indol-2-yl]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1285964.webp&w=3840&q=75)
![Risedronate Related Compound C ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid))](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604643.webp&w=3840&q=75)
![Clomipramine Related Compound F (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1140292.webp&w=3840&q=75)
![Famotidine Related Compound E (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguan…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1269254.webp&w=3840&q=75)
![Mirtazapine Related Compound B (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]be…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1444235.webp&w=3840&q=75)
![Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]pi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1592792.webp&w=3840&q=75)
![Rivastigmine Related Compound B ((R,S)-3-[1-(Dimethylamino)ethyl]phenyl dimethylcarbamate)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1604870.webp&w=3840&q=75)
![Rabeprazole Related Compound D (2-({[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl}sulfonyl)benzi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1598053.webp&w=3840&q=75)